Early perfusion changes in patients with recurrent high-grade brain tumor treated with Bevacizumab: preliminary results by a quantitative evaluation
Antonello Vidiri*, Andrea Pace, Alessandra Fabi, Marta Maschio, Gaetano M Latagliata, Vincenzo Anelli, Francesca Piludu, Carmine M Carapella, Giuseppe Giovinazzo and Simona Marzi